SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " adjusted " 135 found 🔀 AI-powered Shuffle
CVS Health Q1 Earnings Call Highlights
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn
AMC Entertainment Q1 Earnings Call Highlights
AMC Entertainment (NYSE:AMC) reported what Chairman and CEO Adam Aron called its “best Adjusted EBITDA first quarter result since 2019 pre-pandemic,” highlighting a $96 million year-over-year improvement as box office trends strengthened and per-patron economics hit records. First-quarter performan
AMC Entertainment Q1 Revenue Jumps 20% Amid Box Office Recovery
The biggest theater group in the U.S. and globally, AMC Entertainment, said strong domestic performance and “vastly improved” international results across its European footprint boosted first quarter revenue, which topped $1 billion from $862.5 million the year before. Adjusted EBITDA (earnings before interest, taxes, depreciated and amortization) was a positive $38.3 million compared to negative …
Strip casino giant posts steady revenue but lower earnings in Las Vegas
Net revenues were essentially flat and adjusted earnings were down to start the year for the Strip’s largest casino operator.
Caesars Entertainment reports growth in regional properties, big gains in digital segment
Caesars Entertainment Tuesday reported slight increases year-over-year in revenue and adjusted earnings, owing the latter to a 61% increase in its digital segment. The company reported $2.9 bill...
Politics & Power: Rising tariffs, gas prices squeeze small business margins across the South
Florida State University business analyst Wayne Hochwarter joins News4JAX anchor Bruce Hamilton on this week's episode of Politics & Power to discuss whether tariffs should be adjusted to shield small importers; what short‑term relief (tax credits, grants, fuel support) would help Main Street; and how state budgets should adapt to tourism and construction slowdowns.
Politics & Power: Rising tariffs, gas prices squeeze small business margins across the South
Florida State University business analyst Wayne Hochwarter joins News4JAX anchor Bruce Hamilton on this week's episode of Politics & Power to discuss whether tariffs should be adjusted to shield small importers; what short‑term relief (tax credits, grants, fuel support) would help Main Street; and how state budgets should adapt to tourism and construction slowdowns.
Penn Entertainment reports revenue of $1.4 billion for the first quarter of 2026
Penn Entertainment on Thursday morning reported revenues of $1.4 billion for the first quarter of 2026. Segment Adjusted EBITDAR was $471.4 million. “We are pleased to report another solid qua...
Kustom Entertainment enacts 1-for-5 reverse split
Kustom Entertainment implements a 1-for-5 reverse stock split and reduces authorized shares, aiming to meet Nasdaq’s $1.00 bid price requirement while trading begins on a split-adjusted basis.
Broker Marsh's profit rises on strong risk and insurance business
Insurance broker Marsh reported a rise in first-quarter adjusted profit on Thursday, driven by robust results in its risk and insurance services unit.
Angels’ Jorge Soler Gets Decision on Suspension Appeal After Brawl
MLB adjusted Los Angeles Angels slugger Jorge Soler's punishment following his appeal after he received a seven-game suspension. The post Angels’ Jorge Soler Gets Decision on Suspension Appeal After Brawl appeared first on LA Sports Report.
A Look At Caesars Entertainment (CZR) Valuation After Its Mixed Earnings-Driven Share Price Move
Caesars Entertainment (CZR) is back in focus after its latest earnings report, where revenue topped analyst forecasts while adjusted operating income and EPS came in below expectations, yet the share price moved higher. See our latest analysis for Caesars Entertainment. The latest move higher in Caesars Entertainment's share price comes after its earnings release, with the stock showing a 13.54% year to date share price return while the 5 year total shareholder return is still down 69.86%...
Radiology Partners reportedly eyeing international expansion
America’s largest radiology group has purportedly considered making a bid to buy its Australian counterpart, which tallied over $176 million in adjusted earnings last year.
Using adjusted breakout age to help you evaluate wide receivers in the 2026 NFL Draft for fantasy football
Stephen Miller Is Still Pursuing His Immigration Agenda, but More Quietly
Far from acknowledging defeat, Stephen Miller appears to have adjusted his strategy in an effort to minimize political fallout. He has remained steadfast in his view that the administration should act to reverse openness to migration.
A Look At Live Nation Entertainment (LYV) Valuation As Concerts Hit Records And Global Expansion Accelerates
Why Live Nation’s 2025 milestones have investors’ attention Live Nation Entertainment (LYV) is back in focus after reporting record adjusted operating income in its Concerts segment for 2025, hosting 159 million fans and outlining new venue openings across Latin America, Europe, and the U.S. See our latest analysis for Live Nation Entertainment. Live Nation’s latest results arrive after a 7.11% 90 day share price return and a 13.35% 1 year total shareholder return, which build on a very large...
Unity Releases Preliminary First Quarter Results Exceeding Guidance; Will Enhance Growth and Profitability by Exiting Non-Strategic Ad Businesses
Unity (NYSE: U), the world’s leading game engine, today announced preliminary revenue and Adjusted EBITDA for the first quarter 2026 above guidance. Unity ex...
Your Thymus and Your Healthspan
Our thymus gland plays a central role in the development or our immune system, specifically for supporting T cell development (how these cells got their name, maturation and differentiation in the thymus) and discriminating between self and foreign, non-self antigen proteins with production of dendritic cells. As we age, our thymus gland shrinks—the process known as involution—with progressive change from spongy to fatty tissue, with loss of functionality. But this process, with respect to timeline and extent, markedly varies from one person to the next. And to make things even more complicated, our thymus gland anatomy and precise location in the chest also is highly variable. So the famous Frank Netter diagrams from the 1960s (such as at left below) don’t capture the remarkable heterogeneity that a random set of 12 chest CT scans (below at right). What I consider as 2 landmark papers in Nature this week (here and here) used AI to quantify health of the thymus in 2 large cohorts, and then correlate the metric to a broad array of health outcomes. In this edition of Ground Truths, I’m going to cover three questions: (1) How was thymus health determined by AI?; (2) How is thymus health linked to key clinical outcomes? and (3) Are there ways we can promote a healthy (aka rejuvenate) thymus gland in our later years? Subscribe 1. How was thymus health determined by AI? This was accomplished by extensive work developing and validating an AI pipeline for 2 stages, the first for localization and segmentation of the thymus bed, and the second to quantify a digital marker, termed the thymic health score. There’s a lot to this algorithmic development, so I won’t go into all the details, but just provide a rudimentary outline of what was done. The 1st stage used supervised learning with 2 radiologists reviewing 2,461 chest CT scans. That work trained a 3D U-Net model to automatically identify the thymic bed’s 3D cropped region using center of mass coordinates, which reached 99.8% accuracy. The 2nd stage used a foundation model that was pre-trained with SwAV (which stands for Swapping Assignment between multiple Views), a self-supervised model, that generated a high-dimensional thymus representation of 4,096 features. That compares to the radiology reductionist and subjective scoring of 0 to 3 where 0 means the thymus is fully degenerated and fatty, and 3 is considered dense, intact glandular soft tissue. Notably, the self-supervised learning (SSL) performance was superior to supervised (AUC ~0.75 vs 0.55, respectively) reflecting the shallowness of the 0-3 classifier vs SSL’s holistic, self-taught AI. The thymic health score ranged from 0 to 100, with the highest number indexed to fully preserved thymic health. The algorithmic work extended to explainability with both Shapely value distribution, meaning the model was holistic not relying on any “magic” pixel, and occlusion sensitivity, demonstrating the model’s performance was not affected by ribs, sternum, lung tissue, but rather focused on the thymic bed directly. Below are a few saliency maps from the occlusion sensitivity that indicate the thymic bed focus, not affected by neighboring structures, using the jet color scale. Now the AI was ready for processing ~25,000 CT scans, each over 30 MB files, from the 2 large participant cohorts to provide a thymic health score, it did so in less than 14 hours, which is less than 2 seconds per scan! Share 2. How is thymus health linked to key clinical outcomes? The two cohorts were the National Lung Screening Trial, NLST (N=25,031) and the Framingham Heart Study, FHS (N=2,581) each with baseline demographics and long term follow up of >12 years for health outcomes. From the NSLT, you can see below that increased age and body-mass index were correlated to reduced thymic health. And, overall, men had reduced thymic health scores compared with women. There are a lot of graphs in the paper for outcomes, for both the NLST and FHS cohorts. To simplify the major outcomes, below is a composite Figure with striking reduction of all-cause mortality and for the different causes of death. The results were consistent between the 2 cohorts. For example, the cardiovascular mortality hazard ratio average was 0.57 in NLST and 0.38 in FHS (weighted to be 0.53 for the aggregate). The reduction of mortality also extended to digestive diseases and pulmonary disease (data not shown below). Lung cancer incidence was reduced by 36% for high vs low thymic health (Figure below, with a panel -incidence and b panel-mortality, adjusted for age, sex, BMI, smoking status). Notably, there was a smoker’s paradox: lower incidence and improved survival for lung cancer in smokers who had a high thymus health score. Smoking was associated with lower thymic scores whereas alcohol was not. Higher thymic health was linked to higher HDL cholesterol, lower triglycerides, lower fasting blood glucose, and lower systolic and diastolic blood pressure. Inflammation biomarkers, such as C-reactive protein and interleukin-6, were elevated in the people with lower thymic health scores. In their second paper, the same team looked at the relationship between thymic score and outcomes for 3,476 patients receiving cancer immunotherapy. The non-small cell lung cancer progression-free survival was reduced in patients with low thymic health score. A parallel relationship for survival was seen for other types of cancer including melanoma, breast, and kidney with a 44% lower risk among high thymic scores (Figure). A similar pattern was seen with different immune checkpoint inhibitors. The thymus health score outperformed programmed death ligand-1 (PD-L1)and tumor mutation burden (TMB) assay of the tumor and was an independent prognostic marker of progression-free survival. In this dataset, a direct connect with thymus score and adaptive immune function was noted with a correlation before cancer treatment for both T-cell diversity and thymus T-cell production (a metric known as T cell receptor excision circles). Thymus Removal Study There is a highly relevant citation about thymus function before moving onto ways to rejuvenate it. In 2023, a very important study of thymus removal during cardiothoracic surgery was published, with 1146 patients undergoing thymus removal vs 1146 matched controls (mean age 55 years). The adverse outcomes for thymus removal were striking, with a 2.9 higher risk of all-cause mortality and doubling of cancer incidence, 1.5 fold increase in cancer mortality, and 1.5-fold increase in autoimmune diseases. The immune function showed marked compromise after thymus removal, as reflected by CD4+ and CD8+ T cells (Figure below) Share Ground Truths 3. Are there ways we can promote a healthy (aka rejuvenate) thymus gland in our later years? In recent months we’ve learned a lot about the process of thymus involution and the pathways by which this may be modulated. Thymus involution is primarily due to loss to thymus epithelial cells (TECs) and there are 2 subtypes with different functions: the cortical, responsible for positive selection of T cells, and the medullary, for negative selection. When adipose tissue infiltrates the thymus, thymic adipocytes are pro-inflammatory, knocking out T-cell output. Likewise, systemic inflammation, or “inflammaging,” from smoking, obesity, and chronic stress promote thymic adipocytes. Now, from preclinical studies, we know about key pathways that account for these processes. Historically, back in 2014, FOXN1 was recognized as a single master transcription factor essential for TEC function, with studies in mice with forced FOXN1 upregulation leading to thymus regeneration. That laid the foundation for potential regrowth of quiescent thymus cells. It took awhile to find pathways to accomplish this goal and to even refute its role as the master regulator. The Liver-Thymus Axis Feng Zhang and his team recently showed that injection of an mRNA vaccine to the liver encoding DLL1, IL-7 and FLT3-L in combination, factors known to support thymopoiesis (Figure), successfully enhanced immune function in aged mice. However, the effect was transient. The FGF21 Story Two reports in 2025 addressed the thymus gland’s production of FGF21, a growth factor (fibroblast growth factor 21) and its control of thymus involution. This growth factor is also produced by the liver, but it doesn’t have impact on the thymus in aged rodent models. In contrast, The liver’s hepatocyte growth factor (HGF) has been shown to reverse senescent TEC structural changes. Growth hormone stimulates production of insulin growth factor-1 (IGF-1) in the liver and the thymus. Two small studies in human participants (TRIIM, for Thymus Regeneration, Immunorestoration, and Insulin Mitigation) of 6 and 50 people, respectively, treated with combined human growth hormone, metformin and DHEA, suggested the potential of slowing epigenetic aging and improving thymus mass and function. But the combination of drugs, small sample, and lack of controls make conclusions murky. Increased thymus FGF21 led to increased CD8 T cells in old mice and extended healthspan and improved physical performance. Building on the previous FOXN1 data, ablation of β-klotho, the obligatory co-receptor for FOXN1, accelerated thymic aging. The benefit to FGF21 was confirmed in a companion paper using an FGF21 knock-in mouse model showing thymus enlargement and increased TECs throughout the lifespan. (schematic Figure below). The accompanying editorial for these 2 papers speculated: “The proposed link between age-associated thymus involution and organismal aging is intriguing, and suggests we might seek to achieve systemic rejuvenation by counteracting thymic involution.” Other Factors Lessons from the Axolotl (Mexican Salamander) In an elegant set of experiments of the axolotl (Figure), known for its complete thymus regeneration after total surgical removal, mediators were identified. Surprisingly FOXN1 was dispensable. But midkine, a growth factor, appeared to be the driver, the initiator of thymus cell growth, survival, and repair. Other components that contributed were Postn+ (periostin-expressing mesenchymal niches) and Ccl19, a chemokine protein from the bloodstream. RANK and RANKL RANK (receptor activator of nuclear factor κB its ligand (RANKL) have been considered key regulators of medullary TECs. In a study of both aged mice and human thymus cell cultures, their key role was confirmed, with multiple benefits of resorting TEC function, recruitment of progenitor cells, and T cell development. Subscribe Summing Up This body of work strongly supports the health of the thymus gland as a critical regulator of human healthspan, not just a correlate or link. The new landmark studies are reinforced by the regenerative biology experimental models that have shown, via an array of mediators, that healthspan of aged mice is at least in part dependent on thymus gland function and its critical role for maintaining adaptive immunity. It sure seems that we’d be better off having an immune reservoir of naive T cells instead of a profile in older adults of exhausted, low quality, memory T cells, with a senescent phenotype. It is striking that we ignored the importance of the thymus gland for many decades. A wake-up call was the results of the thymectomy matched control study reviewed here, with the opposite of high thymic health score improved health outcomes. The convergence of AI and healthspan here is notable. The exceptional and laborious work for developing and validating (no less explaining) the AI to quantify thymus health set the foundation for probing the connect the major health outcomes in two cohorts with extensive follow-up. We’ve never had a way to meaningfully quantify the thymus gland before, so this represents important leverage of supervised, self-supervised, and transformer models. The study wouldn’t have been possible without AI. And it begs the question as to whether there are ways we can maintain our thymus at a high health score. But it’s not so simple to rejuvenate our thymus. There are multiple risks including the induction of autoimmunity, increasing the risk of cancer, and inducing a pro-inflammatory state. For example, factors that increase TEC proliferation could compromise the medulllary negative selection process and leak out auto-reactive (self-attacking) T cells. Thymic cells could be induced to proliferate, but we know, for example, that growth hormone and IGF-1 are associated with an increase risk of cancer. If thymus rejuvenation doesn’t clear out the accumulated senescent cells in older adults, then inflammation within the gland could block the production of TECs. Keeping these risks in mind, we now have identified many ways to keep our thymus healthy as we age that undoubtedly will be tested in clinical trials going forward. Ultimately, the benefit-to-risk tradeoffs will be defined. In the meantime, we have desperately needed an immunome. As I’ve stressed in multiple prior Ground Truths, we have no test in the clinic to assess a patient’s immune status! It was very encouraging for me to get an email from Hugo Aerts, the senior author of the landmark papers in the days after they were published: “I also wanted to say that your Substack on “Why We Need an Immunome” was inspiring for this work. We found it a very compelling perspective and greatly enjoyed reading it.” Just having an assessment of a person’s immune status via a chest CT scan, with millions of these performed per year, might help in guiding the right immunotherapy for cancer (e.g. more intensive, combinations for those with low thymic health scores) and help define people who are increased risk for age-related diseases of cancer, cardiovascular, and neurodegenerative. The main theme of Super Agers is that we now have many layers of data (genetics, proteins, biomarkers, organ clocks that can be integrated via multimodal AI) for us to define a person’s specific risk decades before one of these age-related diseases leads to symptoms, enabling prevention. From the new studies this week, we can add thymus health score as yet another way to understand a person’s risk, a window into their adaptive immune system and healthspan. And perhaps someday we will be able to safely rejuvenate the thymus, or maintain its health through one’s life, and use the thymus health score to monitor. NB: I wrote this post (No A.I.) A Quick Poll Loading... ********************************************************************* Thanks to Ground Truths subscribers (now > 200,000) from every US state and 212 countries. Your subscription to these free essays and podcasts makes my work in putting them together worthwhile. Please join! If you found this interesting PLEASE share it! Share Ground Truths Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don’t hesitate to post comments and give me feedback. Let me know topics that you would like to see covered. Leave a comment Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. It enabled us to accept and support 47 summer interns in 2025! We aim to accept even more of the several thousand who will apply for summer 2026.
Issues & Ale: It's Just Politics
Join Michigan Public's Political Director Zoe Clark, Senior Capitol Correspondent Rick Pluta, and their FAQ Squad panelists as they give you the facts of the upcoming election cycle!
WEBTOON Entertainment Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Full Year 2025 Revenue Growth of 2.5%; Year-Over-Year Revenue Growth on a Constant Currency Basis of 3.9% Full Year 2025 Net Loss of $373.4 Million; Adjusted EBITDA of $19.4 Million Strong Balance Sheet With Cash And Cash Equivalents of Approximately $582 Million and No Debt LOS ANGELES, March 03, 2026 (GLOBE NEWSWIRE) -- WEBTOON Entertainment Inc. (Nasdaq: WBTN) (“WEBTOON Entertainment” or “the Company”), a leading global entertainment company and home to some of the world’s largest storytellin
Flutter Entertainment (FLUT) Reports Strong 2025 Growth Led by FanDuel and International Expansion
Flutter Entertainment (NYSE:FLUT) is one of the stocks with explosive growth potential. On February 26, Flutter Entertainment reported strong top-line momentum for Q4 2025, with group revenue increasing 25% and adjusted EBITDA rising 27%. The company’s US division, anchored by FanDuel, remained a primary growth engine, posting a 33% increase in revenue and 90% in […]
Galaxy Entertainment Group Reports Q4 & Annual 2025 Results
Leading Macau’s Non-Gaming Diversification Through Mice, Entertainment Events and Live Sports Q4 2025 Group Adjusted EBITDAUp 33% YoY and Up 29% QoQ to $4.3 Billion FY2025 Group Adjusted EBITDA Up 19% YoY to $14.5 Billion FY2025 Group NPAS Up 22% YoY to $10.7 Billion Recommends a Final Dividend of $0.80 Per Share Capella at Galaxy Macau Grand Opened on February 10 HONG KONG, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galaxy Entertainment Group (“GEG”, “Company” or the “Group”) (HKEx stock code: 27) today
Enerflex Ltd. Announces Fourth Quarter 2025 Financial and Operational Results, Agreement to Divest Non-Core Business and Provides Preliminary Outlook for 2026
ADJUSTED EBITDA OF $123 MILLION AND RECORD FREE CASH FLOW OF $141 MILLIONREDUCED NET DEBT TO $501 MILLION OR APPROXIMATELY 1.0x TTM ADJUSTED EBITDA AT THE END OF Q4/25STRONG OPERATIONAL VISIBILITY WITH ES AND EI BACKLOG OF $1.1 BILLION AND $1.3 BILLION, RESPECTIVELYSIGNED AN AGREEMENT TO DIVEST OPERATIONS IN ASIA PACIFIC REGION, CONTINUING EFFORTS TO OPTIMIZE AND SIMPLIFY ENERFLEX’S BUSINESSCAPITAL EXPENDITURES FOR 2026 TARGETED AT $175 TO $195 MILLION, INCLUDING $90 TO $100 MILLION FOR GROWTH O
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Revenue of approximately $2.35 billion, up 59% year-over-year in 2025 Net income of $128 million; Adjusted EBITDA of $318 million in 2025 Subscribers grew to over 2.5 million, up 13% year-over-year in 2025 Provides Q1 and full year 2026 guidance1, with full year 2026 revenue in the range of $2.7 billion to $2.9 billion and Adjusted EBITDA in the range of $300 million to $375 million Hims Hers Health, Inc. (“Hims Hers” or the “Company”, NYSE: HIMS), the leading health and wellness platform, today announced financial results for the fourth quarter and full year ended December 31, 2025 in a shareholder letter that is posted at investors.hims.com. “More than 2.5 million subscribers now rely on us for a healthcare experience that is both accessible and deeply personal – and we believe we’re well on our way to becoming the global leader in consumer health,” said Andrew Dudum, co-founder and CEO. “In 2025, we made it possible for more customers across the world to depend on us
2025 Full-Year results: Excellent financial performance reflecting the strengths of Nexans’ business model
2025 Full-Year results Excellent financial performance reflecting the strengths of Nexans’ business model Exceptional level of organic growth at +8.3% in 2025Strong Adjusted EBITDA margin increase at 11.9% of standard salesPortfolio rotation – Exclusive negotiations entered into for the sale of AutoelectricSolid balance sheet enabling to step-up M&A activityEntering 2026 with confidence with the full deployment of our Global Electrification Pure Player model Preliminary statement : In compliance
BP reports fourth-quarter 2025 profits in line with expectations
BP posted a fourth-quarter underlying replacement cost profit, or adjusted net income, of $1.54 billion on Tuesday, compared with expectations of $1.55 billion in a company-provided poll of analysts and $1.17 billion a year ago.
Tier list that predicts how characters will be adjusted in the upcoming balance patch for Street Fighter 6 released by Broski
Alex will be joining Street Fighter 6 as the next character of the Season 3 Pass on March 17, 2025. A major balance patch featuring changes for every fighter will also be released on that date.The community's dissatisfaction ...
Why The Tencent Music Entertainment Group (NYSE:TME) Story Is Shifting After Mixed Analyst Calls
Tencent Music Entertainment Group’s latest update keeps its fair value estimate broadly steady, shifting only slightly from US$26.92 to US$26.84 as the model digests mixed analyst reactions to recent earnings. With the discount rate adjusted marginally lower from 9.72% to 9.63% and revenue growth assumptions held effectively unchanged at about 15.19%, the price target move reflects a fine tuning of risk and growth expectations rather than a wholesale rethink of the story. Stay tuned as we...
AMD Sales Climb on Help From Data-Center Business
Stripping out certain one-time items, adjusted per-share earnings were $1.53, ahead of the $1.32 anticipated by analysts.
Several Upstate VA Health Care System Operations to close due to travel conditions
According to officials, facility operations are being adjusted to ensure the wellbeing and safety of patients and staff.
What Live Nation Entertainment (LYV)'s Earnings Beat but Revenue Miss Means For Shareholders
In the past few days, Live Nation Entertainment reported quarterly results that exceeded analysts’ adjusted operating income estimates but fell short on revenue and event volume expectations, prompting a mixed reaction from the market. At the same time, analysts remained divided, with some reaffirming positive views based on continued demand for live events while others downgraded the stock amid ongoing concerns about the Ticketmaster business. We’ll now look at how this adjusted operating...
NVIDIA reportedly shifts RTX 50 supply toward RTX 5060 and 5060 Ti 8GB in 2026
NVIDIA said to be focusing on 8GB models now A new report from China claims NVIDIA adjusted its RTX 50 series supply plan for 2026 due to rising memory
Mount Horeb small business launches cream liqueur made with Wisconsin dairy
A small business in Mount Horeb recently launched a new cream liqueur that’s already in more than 50 locations across the state.
RSM US Middle Market Business Index Improves on Rising Revenues and Earnings
The RSM US Middle Market Business Index (MMBI), presented by RSM US LLP ("RSM") in partnership with the U.S. Chamber of Commerce, rose to 131.5 in the fourth quarter from 123.3 in the prior period on a seasonally adjusted basis. The survey results are supported by rising revenues and earnings and reflect growing optimism among middle market firms, even as attitudes on the general economy remain sour.
How Recent Changes Are Shaping the Story Behind Beauty Health's Valuation
Beauty Health stock has recently seen its price target adjusted, with the fair value estimate holding steady at $1.93 despite some shifts in underlying assumptions. The primary driver behind this update is a lowered discount rate, which reflects analysts' increased confidence in management's ability to reduce risk and reinforce revenue stability. Stay tuned to learn how you can follow new developments and better understand the evolving narrative behind Beauty Health's valuation. Analyst Price...